albuterol (Armstrong Albuterol HFA) + Albuterol Sulfate (Provenetil-HFA) + Placebo-HFA

Phase 3Terminated
0 watching 0 views this week๐Ÿ“ˆ Rising
72
Hype Score

Development Stage

โœ“
Pre-clinical
โœ“
Phase 1
โœ“
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Asthma

Conditions

Asthma, Bronchospasm

Trial Timeline

Feb 1, 2008 โ†’ Oct 1, 2008

About albuterol (Armstrong Albuterol HFA) + Albuterol Sulfate (Provenetil-HFA) + Placebo-HFA

albuterol (Armstrong Albuterol HFA) + Albuterol Sulfate (Provenetil-HFA) + Placebo-HFA is a phase 3 stage product being developed by Amphastar Pharmaceuticals for Asthma. The current trial status is terminated. This product is registered under clinical trial identifier NCT00634829. Target conditions include Asthma, Bronchospasm.

Hype Score Breakdown

Clinical
27
Activity
18
Company
5
Novelty
9
Community
10

Clinical Trials (1)

NCT IDPhaseStatus
NCT00634829Phase 3Terminated